John Tan

John Tan

Reed Smith

Contact  |  View Bio  |  RSS

Latest Posts › Licenses

Share:

China Life Sciences and Health Industry Client Briefing – November 2012 (December 13, 2012)

In This Issue: Priorities, Practical Tips and Lessons Learned from Reed Smith’s China Device Regulatory Briefing on December 4, 2012; Programs of Designated Drug Production to be Initiated: Five to 10 Pilot Varieties...more

12/17/2012 - China FDA Licenses Life Sciences Medical Devices Pharmaceutical Stem cells

1 Results
|
View per page
Page: of 1